SkinBioTherapeutics's total assets for Q2 2023 were £4.21M, an increase of 62.34% from the previous quarter. GB:SBTX total liabilities were £560.34K for the fiscal quarter, a -6.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.